Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Strong Trading Volume – What’s Next?

Posted by Danessa Lincoln on Jul 11th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) shares saw unusually-strong trading volume on Thursday . 302,556 shares were traded during mid-day trading, an increase of 126% from the previous session’s volume of 134,092 shares.The stock last traded at $12.1050 and had previously closed at $12.20.

Analysts Set New Price Targets

Separately, Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a report on Tuesday, June 23rd. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy”.

Check Out Our Latest Research Report on FSNUY

Fresenius SE & Co. Stock Performance

The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41. The firm has a 50-day moving average price of $11.42 and a two-hundred day moving average price of $13.02. The firm has a market cap of $27.44 billion, a PE ratio of 16.24 and a beta of 0.63.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). The firm had revenue of $6.75 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.09% and a net margin of 6.55%. Research analysts forecast that Fresenius SE & Co. will post 1.03 EPS for the current fiscal year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.